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Recent studies from this laboratory have shown a  striking difference in the ability 
of mouse macrophages to ingest blood-form trypomastigotes (BFT) 1 of the Y and CL 
strains  of T~ypanosoma  cruzi,  as compared with  metacyclic trypomastigotes  grown  in 
culture.  This  was  the  result  of an  anti-phagocytic  factor,  present  on  the  surface  of 
BFT,  that  could  be  either  removed  by  trypsinization  or  nullified  with  specific 
hyperimmune serum.  Such treatments  were without  influence on their  intracellular 
fate when ingested by resident  or inflammatory macrophages. However, when taken 
up by lymphokine-activated  macrophages,  BFT were readily destroyed,  as were the 
metacyclic trypomastigotes (1). 
The  presence  of this  antiphagocytic  material  lead  us  to  investigate  the  surface 
components of both culture-form trypomastigotes and BFT. In this article, we report 
that  BFT  possess  a  major 90,000-relative  molecular weight  (Mr)  surface  membrane 
glycoprotein of isoelectric  point  (pI)  5.0,  which  is  readily cleaved by trypsin  and  is 
precipitated  by both  human  and  murine  immune  sera.  This  component  is  absent 
from metacyclic trypomastigotes and epimastigotes  from aeellular cultures and may 
be responsible for the anti-phagocytic effect. 
Materials  and Methods 
Mice.  Male and female A/J, C57BL/10J (The Jackson Laboratory, Bar Harbor, Maine), 
and Swiss mice (The Rockefeller University, New York) were used at 6-8 wk of age. 
Parasites.  The Y and CL strains of T. cruzi were obtained from Dr. R. Nussenzweig (New 
York University School of Medicine,  New York) and  maintained  by weekly passage in A/J 
mice. BFT were purified from heparinized blood of 7-d infected untreated mice or 5-d infected 
irradiated mice (irradiated 2 d before infection with 500 rad from a Cesium source). Parasites 
were  collected  after  cell  separation  on  Ficoll-paque  (Pharmacia  Fine  Chemicals,  Div.  of 
Pharmacia,  Inc., Piscataway, N. J.).  They were washed  once at  4°C in  phosphate-buffered 
saline  (PBS), and further purified in a Metrizamide  (Nyegaard and Co. A/S, Oslo, Norway) 
gradient  (2)  to reduce the number of contaminating mononuclear cells  and  platelets.  Some 
platelets still remained in samples prepared from nonirradiated mice. Culture-form trypomas- 
tigotes were grown from blood stabilates in liver-infusion tryptose (LIT) medium. Metacyclic 
trypomastigotes were purified from 4-wk old LIT cultures by complement lysis ofepimastigotes 
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followed  by  separation  of live  trypomastigotes in  a  Metrizamide  gradient,  as  previously 
described (2). Epimastigotes were obtained from 2 wk-old LIT cultures (99% epimastigotes) or 
as the major form (70-80%) from 4-wk-old samples. 
Cell Surface Iodination.  Purified parasites were washed twice by centrifugation (400 g for 10 
min at 4°C) in PBS and plasma membrane proteins radioiodinated using a slight modification 
of the lactoperoxidase-glucose  oxidase method of Hubbard and Cohn (3). Reagents used were 
lactoperoxidase (purified grade) from Calbiochem-Berhring Corp., American Hoeclost Corp., 
La Jolla, Calif. Glucose oxidase (type V), and trypsin (type III from bovine pancreas)  from 
Sigma Chemical Co.,  St.  Louis, Mo.  Carrier-free Na[125I] was obtained from New  England 
Nuclear, Boston, Mass. 100% of the parasites were found to be viable and actively motile after 
radiolabeling. Parasites were  washed  free of the  radiolabel and  whole  lysates prepared by 
solubilization in lysis buffer (PBS that contained 0.5% Nonidet P-40 [NP-40; Bethesda Research 
Labs., Bethesda, Md.],  100 U/ml aprotinin, and  1 mM phenylmethylsulfonylfluoride [Sigma 
Chemicals Co.]). 
[asS]Methionine Labeling of Parusites.  Purified parasites were incubated for 3 h at 37°C with 
0.5 mi of methionine-free, a-modified Eagle's medium that contained 100 #g/ml bovine serum 
albumin  (BSA) and 50 #Ci of [36S]methionine (500  Ci/mmol)  (Amersham Corp., Arlington 
Heights, Ill.). 
Immune Precipitation.  For isolation of [SSS]methionine-labeled cell surface components, par- 
asites were resuspended after radiolabeling in 0.5 ml of PBS that contained 700/xg of human 
immune IgG or a  1:4 dilution of mouse hyperimmune serum, and incubated for 20 min at 4°C. 
Cells were then washed by centrifugation in PBS (400 g for 10 min), and resuspended in lysis 
buffer. After centrifugation (23,000 g for 20-40 min) to remove nuclei and debris, the immune 
complexes formed in  the initial incubation were isolated using  Protein A-Sepharose 4B,  as 
described below. 12BI-labeled parasite lysates were clarified by eentrifugation (23,000  g for 20 
min) and 100 #1 of clarified supernates were incubated with 35 #g of human immune IgG or 5 
/~1 of mouse hyperimmune serum for  1 h  at 4°C, with constant agitation. Antigen-antibody 
complexes were collected using 30 #1 of a 30% suspension of Protein A-Sepharose 4B (Pharmacia 
Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.), and incubated for 1 h at 4°C with 
constant agitation. The beads were then centrifuged, washed twice at 4°C in sah-azide buffer 
(0.2  M  NaCI;  12.5 mM  potassium  phosphate,  pH  7.4;  and  0.02%  NaNa),  twice  at  room 
temperature  (RT)  with a  mixed-detergent solution  (4)  (0.05%  NP-40, 0.1%  sodium dodecyl 
sulfate SDS, 0.3 M  NaC1,  10 mM Tris-HC1, pH 8.6)  and twice again with salt azide buffer. 
Controls for nonspecific binding were performed by incubation of lysates with 8 #1 of normal 
human serum, 5 ~1 of normal mouse serum, or with Protein A-Sepharose 4B alone. Antigens 
were  solubilized in  40  #1  of electrophoresis sample  buffer  (2%  SDS,  12%  sucrose,  0.01% 
bromophenol blue, 50 mM DTT, and 50 mM Na2COa buffer, pH 8.6)  and boiled for 2 min. 
All samples were stored at -70°C until used. 
Binding to Lectin.  100-#1  samples in lysis buffer were incubated for 1 h at 4°C with constant 
agitation with 50 #1 of a  30% suspension of eoncanavalin A-Sepharose 4B  (Pharmacia Fine 
Chemicals, Piseataway, Div. of Pharmacia, Inc.) in PBS. Controls for nonspecific binding were 
performed by incubating the samples in the presence of 0.25  M  a-methyl mannoside (Sigma 
Chemical Co.).  Samples were then centrifuged at 4°C,  washed twice in salt-azide buffer at 
4°C, twice in detergent solution at RT (0.05% NP-40, 0.3 M  NaC1,  10 mM Tris-HCl, pH 8.6) 
and once more with salt-azide buffer. Samples were eluted in 40 #1 of electrophoresis sample 
buffer and boiled for 2 min. 
Polyacrylamide Gel Electrophoresis (PAGE).  Samples were electrophoresed in l-ram thick slab 
gels with a 4-11% polyaerylamide gradient in the running gel (5). Gels containing 35S-labeled 
samples were processed for fluorography (6) and exposed on prefogged Kodak X-Omat R-1 
film (Eastman Kodak Co., Rochester, N. Y.) at -70°C (7). 125I samples were dried and exposed 
on Kodak X-Omat R-1 film with image intensification screens (Kronex Lighting Plus; E. I. du 
Pont de Nemours & Co., Inc., Wilmington, Del.). 
Two-dimensional  gel  electrophoresis was  performed  as  described  by  O'Farrell  (8).  For 
separation in the first dimension, samples were run under equilibrium conditions. The second 
dimension was run in 4-11% gradient gels as described above. 
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C56BL/10J, or NCS female mice with 5 x  10  e culture forms of the CL or Y strain of T. cmzi 
in PBS. Animals were then subsequently injected  four times  at  15-d  intervals with  105 live 
BFT. Blood was collected 1 wk after the last injection, serum prepared, and stored at -70°C. 
Human Immune IgG.  Human  immune  IgG was  isolated  from  the  blood  of five  patients 
hospitalized  with  chronic  Chagas'  cardiophathy.  This  was  performed  with  the  generous 
cooperation  of Dr.  Sonia  Andrade  and  Dr.  Zilton  Andrade,  and  Dr.  Marcelle  Reesink 
(Department  of Pathology, Federal  University of Bahia,  Brazil).  A  crude  IgG fraction was 
obtained by sodium sulfate precipitation of a plasma fraction (9). Protein determinations were 
done by the Lowry method (10). 
Results 
Externally  Disposed Polypeptides of Cultured Epimastigotes  and T~vpomastigotes, LPO Iodi- 
nation.  Epimastigotes  and  trypomastigotes  of  both  the  Y  and  CL  strains  were 
iodinated and labeled polypeptides displayed on 4-11% gradient  SDS-PAGE. Fig.  1, 
lane  A  illustrates  the  pattern  obtained  when  Y  strain  epimastigotes  (2-wk cultures, 
99% epimastigotes)  were labeled.  The same pattern  is seen for the CL strain.  Fig.  1, 
lanes B  and C  show the profile for culture-form trypomastigotes  (4-wk cultures,  30% 
trypomastigotes),  when  these  were  labeled  before  complement  lysis  and  gradient 
separation,  as  previously  described  (11).  In  each  case,  only  a  single  75,000-mr 
polypeptide  was labeled.  If, however, epimastigotes  were  first  lysed with  guinea-pig 
complement  and  trypomastigotes  were then  purified  and  iodinated,  the profile was 
dramatically  different  (lanes  D  and  E,  for Y  and  CL strains,  respectively).  Many 
additional  labeled peptides were apparent.  The majority of these bands were precip- 
itable with an anti-C3 antibody (not shown), and represent complement components 
adhering to the surface of trypomastigotes. 
Surface Iodination of BP~.  The  iodination  of BFT  gave quite  a  different  labeling 
pattern.  It exhibited  a  major peptide  of 90,000 Mr and  two minor bands of 50,000 
and 55,000 Mr. This pattern was representative of BFT of both the Y  (Fig. 2, lane A) 
and  CL  (Fig.  2,  lane  B)  strains  when  obtained  from  irradiated  mice.  In  contrast, 
FIG.  1.  Iodinated polypeptides on the surface of cultured epimastigotes and trypomastigotes. (A) 
Epimastigotes. (B, C) Trypomastigotes Y strain (B) and CL strain (C) iodinated before separation 
from epimastigotes. (D,  E)  Trypomastigotes, Y strain  (D)  and  CL strain  (E)  iodinated  after 
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FIo. 2.  Iodination profile  of BFT. (A, B) Y strain (A) and CL strain (B) isolated from irradiated 
mice. (C, D) Y strain (C) and CL strain (D) isolated from normal mice. (E) Profile  from platelet 
contaminant obtained by mock  isolation  of trypomastigotes  from noninfected,  nonirradiated mice. 
labeling of BFT prepared from nonirradiated mice yielded a  more complex pattern 
(Fig. 2C and D), with additional labeled polypeptides. These were thought to arise 
from platelets that contaminate the preparation. A sham isolation of parasites from 
uninfected,  nonirradiated  mice  yielded  a  preparation  containing  platelets,  which 
upon iodination gave a  pattern that accounted for some of the major contaminating 
peptides (Fig. 2, lane E). 
Biosynthetic  Labeling  of BFT.  The possible presence of noniodinated surface poly- 
peptides  was  analyzed  by  biosynthetic  labeling  with  [~SS]methionine.  Sufficient 
[~S]methionine was incorporated into BFT protein within 3 h  to be easily detected 
(Fig. 3, lane A) in whole-cell lysates. Labeled surface components were identified by 
incubating viable asS-labeled parasites with either mouse hyperimmune serum  (Fig. 
3,  lane  C)  or an  IgG  fraction from the  plasma  of a  patient  with  chronic Chagas' 
disease  (Fig.  3,  lane  B).  After  incubation  at  4°C  for 20  min,  the  organisms  were 
washed, lysed, and immune complexes were isolated by means of Protein A-Sepharose 
4B. Label was rapidly incorporated into a 90,000-Mr component, which was the major 
surface polypeptide recognized by both human and mouse antibodies. Fig. 3, lane D 
shows  that  this component binds  to concanavalin A-Sepharose 4B and  this can  be 
specifically blocked by the addition of 0.25 M  a-methyl mannoside (Fig. 3, lane E). 
Biosynthetic  Labeling  of Surface Peptides  of Culture-Form  Epimastigotes  and  T~ypomasti- 
gotes.  Both epimastigotes and trypomastigotes purified from acellular cultures also 
incorporated enough [aSS]methionine into their polypeptides within 3 h  to yield the 
whole-cell lysates shown in Fig. 4 (lane A, trypomastigotes; and lane C, epimastigotes). 
Immunoprecipitation of the surface peptides by human immune IgG is shown in lane 
B  for trypomastigotes and  in  lane  C  for epimastigotes.  It  is  clear that  the  major 
peptide recognized is again the 75,000-Mr component that was identified previously 
by iodination. 
Effect  of Trypsinization  on  the  Pattern  of Labeled  Peptides.  Because  trypsinization  of 
BFT resulted in the removal of an anti-phagocytic factor, it was of interest to examine 
the labeled peptide profile after trypsinization. Comparison of BFT surface polypep- NOGUEIRA, CHAPLAN, TYDINGS,  UNKELESS,  AND COHN  633 
Flo.  3.  [a6S]Methionine-labeled  molecules isolated from BFT by immunoprecipitation.  (A) Whole- 
cell lysate, 3 h incorporation.  (B) Surface components immunoprecipitated with a human immune 
IgG fraction (patient 1). ((3) Surface components immunoprecipitated with a mouse hyperimmune 
serum. (D) Products  labeled of whole-cell lysate (A) bound to concanavalin  A-Sepharose 4B. (E) 
Identical to (D) but in the presence of a-methyl mannoside (0.25 M). 
FIG. 4.  [a6S]Methionine  labeling of culture forms. (A) Y strains trypomastigotes, whole-cell lysate, 
3  h  incorporation.  (13) Y strain, trypomastigotes  surface components  immunoprecipitated with 
human immune IgG (patient  2). (C) Y strain, epimastigotes, whole-cell lysate, 3 h incorporation. 
(D) Y strain, epimastigotes, surface components immunoprecipitated with human immune IgG as 
in (B). 
tides before (Fig. 5, lanes A, B, and E) and after trypsinization (Fig. 5 lanes C, D, and 
F)  reveals the loss of a  90,000-Mr  peptide. This is equally true  for parasites labeled 
with  1~I  (Fig. 5, lanes A-D)  and  [aSS]methionine (lanes E-F). Lanes A  and  B  show 
immunoprecipitation patterns for Y  strain, t~I-labeled BFT with mouse and human 634  T,  CRUZI: SURFACE ANTIGENS  OF BLOOD  AND CULTURE  FORMS 
FIG. 5,  Effect  of trypsin treatment of BFT on the immunoprecipitated proteins.  (A) Y strain  - 
immunoprecipitation  of 12hi-labeled  whole-cell lysate with hyperimmune mouse serum. (B) Y strain, 
profile of l~I-labeled  whole-cell lysate with human immune IgG (patient 2). (C) As in (A), parasites 
trypsinized before iodination.  (D) As in (B), parasites trypsinized before iodination.  (E) CL strain, 
[abS]methionine-labeled  surface components immunoprecipitated  with hyperimmune mouse serum. 
(F) As in (E) parasites trypsinized before incubation with hypefimmune  mouse serum. 
TABLE  I 
Reexpression of BFT Anti-Phagocytic Activity After T~ypsinization 
Intracellular  Time after  Infected 
Treatment of parasites  trypsinization  parasites/100 
macrophages  macrophages 
h  % 
None  8  1.5 
Trypsin  0  63  9 
Trypsin  3  25  4 
Trypsin + cycloheximide  3  56  10 
Average of two experiments. BFT (Y strain) were isolated as described in Materials 
and Methods. Parasites were exposed to macrophages either immediately, or 3 h after 
trypsinization. 
antibodies, respectively. Lanes C  and  D  represent  similar samples except that  BFT 
were trypsinized before iodination. It is clear that the 90,000-Mr component is absent 
from these preparations. Lane E  shows the surface immunoprecipitation pattern for 
asS-labeled-CL strain BFT with  mouse  hyperimmune  serum.  Lane  F  is the pattern 
obtained when BFT are trypsinized after the 3-h labeling period. 
Table I shows that BFT begin reexpressing the anti-phagocytic component on their 
surface within 3 h  after trypsinization. This is shown by the inhibition of phagoeytosis 
of trypsinized parasites 3 h  after treatment. The presence of 5/zg/ml of cycloheximide 
inhibits this effect, and it also completely blocks the incorporation of [aSS]methionine 
into BFT polypeptides (not shown). 
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apparent  effect on either the  number or intensity of iodinated or biosynthetically 
labeled polypeptides. 
Surface Antigens  Recognized by a Panel of Human Immune IgG.  IgG fractions obtained 
from the plasma of five patients with Chagas' disease revealed remarkably similar 
immunoprecipitation patterns. Three of such immunoprecipitates are shown in Fig. 
6. These were obtained with [~S]methionine labeled BFT of the Y (Fig. 6 A) and CL 
(Fig. 6 B) strains. 
It is noteworthy that the human and mouse antibodies recognize the same poly- 
peptides on  the parasite surface  (see Fig. 5,  lanes A,  B, and E).  Incubation of the 
antibodies with ~S-labeled whole-cell lysates of the parasites did not bring down any 
major peptide in addition to the ones identified at the surface of the parasites (data 
not shown). Incubation of cell lysates with either normal mouse or human sera does 
not bring down any labeled bands (data not shown). 
Two-Dimensional  Gel Electrophoresis Characterization of the Major Surface Peptides  of T. 
cruzi.  The charge and heterogeneity of the individual polypeptides was next exam- 
ined. Two-dimensional analysis of t25I lysates of metacyclic trypomastigotes, derived 
from acellular cultures, revealed the major 75,000-Mr  band which was quite homo- 
geneous and had a pI of 7.2 (Fig.  7 B). The same analysis from asS-labeled immuno- 
precipitates of BFT  (Fig.  8 B)  shows both  the  90,000-  and 55,000-Mr  components, 
both quite homogeneous. The 90,000-Mr  peptide had a pI of 5.0 and the 55,000  a pI 
of ~4.7. No differences could be detected between the Y and CL strains. 
Discussion 
In this paper, we employed surface and biosynthetic labels coupled with immuno- 
precipitation techniques, to study surface antigens of different stages in the life cycle 
FIo.  6.  lmmunoprecipitation profiles of [anS]methionine-labeled  blood forms with human immune 
lgG fractions. (A) Y strain, human immune IgG fractions from patients 4, 5, and 6. (B) CL strain, 
human immune IgG fractions from Patients 4, 5, and 6. 636  T.  CRUZI:  SURFACE ANTIGENS  OF BLOOD  AND  CULTURE  FORMS 
Fro.  7.  Two-dimensional gel electrophoresis of culture-form trypomastigotes' surface peptides. (A) 
One-dimensional profile of l~I-label~d whole-cell lysate of metacyclic trypomastigotes, CL strain. 
(B) Two-dimensional profile of the same sample in (A). 
Fro. 8.  Two-dimensional gel electrophoresis of BFT surface peptides. (A) One-dimensional profile 
of [~S]methionine-labeled  blood forms, CL strain;  surface components  immunoprecipitated with 
mouse hyperimmune  serum. (B) Same sample run in two dimensions. 
of  T.  cmzi.  By  surface  labeling with  the  LPO  technique  we  demonstrated  several 
peptides on  the surface of BFT, one of which  is a  major glycoprotein of 90,000  Mr. 
Similar labeling of trypomastigotes and epimastigotes from acellular cultures revealed 
that  the  major  labeled  component  was  a  glycoprotein  of  75,000-M,.  Biosynthetic 
labeling  with  [~S]methionine  also  revealed  the  same  polypeptides.  In  this  case, NOGUEIRA, CHAPLAN, TYDINGS, UNKELESS, AND COHN  637 
however, identification required  immunoprecipitation with  immune  sera  obtained 
from both humans and mice. 
The 90,000-Mr peptide from BFT was readily removed from the parasite surface by 
trypsin,  and  was  an  acidic  glycoprotein with  a  pI  of 5.0.  In  contrast,  the  major 
glycoprotein of both epimastigotes and trypomastigotes isolated from acellular cul- 
tures  (75,000  Mr)  was  trypsin  insensitive  and  had  a  pI  of  7.2.  The  90,000-Mr 
glycoprotein found on BFT is likely to be the antiphagocytic surface component (1) 
in view of its trypsin sensitivity, time of reexpression on the plasma membrane after 
trypsinization, pI and absence from culture forms. 
The presence of an iodinated glycoprotein of 90,000 Mr on the surface of BFT is in 
keeping  with  the  results  of Snary  and  Hudson  (12).  These  authors  reported  the 
presence of this component as the major glycoprotein of all life stages of T. cruzi. We 
find a different component on the surface of epimastigotes and metacyclic trypomas- 
tigotes, with a Mr of 75,000. We think it unlikely that the 75,000-Mr component arose 
by proteolysis of the 90,000-Mr component for the following reasons:  (a) We consist- 
ently find a  single component labeled in iodinated lysates of culture forms, and no 
other  fragments  are  seen.  (b)  The  samples  are  lysed  in  the  presence  of protease 
inhibitors, are always handled on ice, and stored frozen at -70°C. (c) All the parasites 
remained  viable  throughout  the  purification  procedures.  In  addition,  the  surface 
glycoproteins  of the  culture  forms  and  those  of the  BFT  have  different  trypsin 
sensitivities. Our data also agree with previous observations by de Souza et al.  (13) 
who reported that BFT have a highly negative surface charge and bind large amounts 
of cationized ferritin, whereas epimastigotes are less negatively charged and bind very 
little cationized ferritin. It is also possible that the difference between the 75,000- and 
the 90,000-Mr components is more easily detected in gradient gels. 
Two experimental artifacts of labeling are worth discussing in more detail. One is 
the  finding  of iodinated  complement  components  on  the  surface  of metacyclic 
trypomastigotes after purification with  guinea pig complement. This suggests that 
these forms may also be able to trigger the alternative pathway of complement (11) 
but are resistant to lysis. However, we cannot rule out the initiation of the complement 
cascade by epimastigotes and  its fixation on trypomastigotes as a  bystander effect. 
The other artifact occurs when BFT obtained from nonirradiated mice are surface 
iodinated.  Here,  the  presence of contaminating  platelets  complicates the  labeling 
pattern, whereas preparations from irradiated animals reveal a much simpler pattern. 
The finding that all mouse and human immune sera tested recognized the same 
components suggest that these are the relevant immunogens of the parasites. Immu- 
35  noprecipitation  of [  S]methionine-labeled  whole-cell  lysates  did  not  identify  any 
major  additional  component  not  identified  by  incubation  of live  parasites  with 
antibodies or by z25I surface labeling. This suggests that surface polypeptides are the 
dominant immunogenic species, and intracellular parasite components play little, if 
any, role in the immune response. 
We do not as yet understand  the immunologic relationship between the  75,000- 
and 90,000-Mr polypeptides. It is possible that  they are closely related peptides, as 
suggested by Snary and Hundson (12), which differ in terms of glycosylation and/or 
other  posttranslational  events.  Alternatively,  they  may  be  totally  unrelated  gene 
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Summary 
The surface polypeptides of both cultured and blood forms of Trypanosoma cruzi were 
iodinated  by the glucose oxidase-lactoperoxidase technique.  Blood-form trypomasti- 
gotes (BFT)  isolated from infected mice displayed a  major 90,000-Mr component. In 
contrast,  both  epimastigotes  and  trypomastigotes obtained  from  acellular  cultures 
expressed a smaller 75,000-Mr peptide. Both major surface components were presum- 
ably glycoproteins in terms of their binding to concanavalin A-Sepharose 4B. 
Within  a  3-h  period,  both  blood  and  culture  forms synthesized  their  respective 
surface glycoproteins (90,000 Mr and 75,000 Mr, respectively) in vitro. [aSS]methionine- 
labeled surface peptides were immunoprecipitated with immune sera of both human 
and  murine origin.  A  panel of sera from patients with chronic Chagas' disease and 
hyperimmunized mice recognized similar surface peptides. These immunogens were 
the same components as the major iodinated species. 
The major BFT surface peptide was readily removed by trypsin treatment of the 
parasites,  although  this  procedure  did  not  affect  the  75,000-Mr  peptide  from  the 
culture forms. Two-dimensional polyacrylamide gel electrophoresis revealed that the 
90,000-Mr peptide found on BFT was an acidic protein of isoelectric point  (pI) 5.0, 
whereas,  the  75,000-Mr  peptide  from culture-form  trypomastigotes has a  pI of 7.2. 
The  90,000-Mr  component  is  thought  to  be  responsible  for  the  anti-phagocytic 
properties of the BFT (1). 
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